BRD4 and cancer: Whereas TAD dysfunction due to boundary misregulation occurs in several cancers, including glioma [121] and T-cell acute lymphoblastic leukemia [122], oncogenic hyperacetylated BRD4-NUT results in pathological long-range interactions within a novel nuclear sub-compartment in NUT carcinoma [29].